SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-106078
Filing Date
2023-10-02
Accepted
2023-10-02 21:50:08
Documents
2
Period of Report
2023-09-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2327445-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2327445-1_3seq1.xml 3 4405
2 EXHIBIT 24 tm2327445d1_ex24.htm EX-24 7574
  Complete submission text file 0001104659-23-106078.txt   13375
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 11058BP
Business Address
Abi-Saab Walid (Reporting) CIK: 0001985973 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 231301487